| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012257816 |
| P356 | DOI | 10.1007/S00393-006-0058-Z |
| P698 | PubMed publication ID | 16670811 |
| P50 | author | Guillermo Ruiz-Irastorza | Q37830875 |
| Munther A. Khamashta | Q73418907 | ||
| P2860 | cites work | Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review | Q28175314 |
| High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin | Q28185196 | ||
| Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis | Q28190493 | ||
| Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment | Q28193717 | ||
| Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies | Q28195353 | ||
| Treatment of pregnancy loss in Hughes syndrome: a critical update | Q28196667 | ||
| Treatment of pregnant patients with antiphospholipid syndrome | Q28196925 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| A study of sixty pregnancies in patients with the antiphospholipid syndrome. | Q33496452 | ||
| Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus | Q33770770 | ||
| Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies | Q33930498 | ||
| The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community | Q33930523 | ||
| Placentation, antiphospholipid syndrome and pregnancy outcome | Q34173981 | ||
| Lupus pregnancy: is heparin a risk factor for osteoporosis? | Q34418809 | ||
| Antiphospholipid syndrome: obstetric diagnosis, management, and controversies | Q35150503 | ||
| Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q35895172 | ||
| Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. | Q36222874 | ||
| Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) | Q36242479 | ||
| Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy | Q36242873 | ||
| Pulmonary arterial hypertension associated to connective tissue diseases. | Q36283465 | ||
| Uterine artery Doppler screening for adverse pregnancy outcome | Q36300962 | ||
| Evaluation of systemic lupus erythematosus activity during pregnancy. | Q40475642 | ||
| Underlying disorders associated with severe early-onset preeclampsia | Q40971826 | ||
| Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies | Q41931544 | ||
| Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation | Q45111033 | ||
| Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. | Q46344245 | ||
| Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome. | Q46351020 | ||
| Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies | Q47869809 | ||
| Systemic lupus erythematosus flares during pregnancy. | Q50974131 | ||
| Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants | Q57837984 | ||
| Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia | Q61415575 | ||
| Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment | Q68139494 | ||
| Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody | Q69946465 | ||
| Anticardiolipin antibodies: clinical consequences of "low titers" | Q71003133 | ||
| Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients | Q72671950 | ||
| Antiphospholipid antibodies in healthy pregnant women | Q73069261 | ||
| Assessing disease activity in SLE patients during pregnancy | Q73198900 | ||
| A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group | Q73388182 | ||
| Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women | Q74384559 | ||
| Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale | Q75828793 | ||
| The eradication of congenital heart block | Q80535717 | ||
| Neonatal lupus syndromes | Q80863095 | ||
| Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases | Q81507513 | ||
| P433 | issue | 3 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 192-4, 196-9 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Zeitschrift fuer Rheumatologie | Q15763293 |
| P1476 | title | Systematic lupus erythematosus and antiphospholipid syndrome during pregnancy | |
| P478 | volume | 65 |
| Q26864495 | Thrombophilia and Recurrent Pregnancy Loss: Is heparin still the drug of choice? | cites work | P2860 |
Search more.